logo
#

Latest news with #IntegratedSystems

QuidelOrtho Launches Certified Analyzer Program
QuidelOrtho Launches Certified Analyzer Program

Malaysian Reserve

time4 days ago

  • Business
  • Malaysian Reserve

QuidelOrtho Launches Certified Analyzer Program

Initiative to expand testing access to underserved U.S. communities SAN DIEGO, Aug. 13, 2025 /PRNewswire/ — QuidelOrtho Corporation has launched a Certified Analyzer Program, an innovative initiative designed to expand access to high-quality diagnostic testing in rural and community hospitals across the United States. Tailored for clinics, physician office labs and small hospitals with fewer than 100 beds, the program offers certified VITROS™ analyzers that deliver proven reliability and quality results, with award-winning service, at a fraction of the cost. 'Our mission is rooted in equipping our customers so they can deliver diagnostic excellence to patients,' said Audra Jones, Senior Vice President, North America, QuidelOrtho. 'By repurposing and rigorously certifying high-performing analyzers, we aim to expand access to reliable diagnostic technology for healthcare facilities that play a critical role in their communities.' Each analyzer in the program undergoes a robust, multi-point certification process at QuidelOrtho's Rochester facility, including over 140 system checks, functional adjustments, hardware cleaning or replacement, and extensive performance testing. These analyzers undergo a comprehensive certification process to align with QuidelOrtho's established quality and performance criteria and include a 12-month warranty on service and support. The program features certified VITROS XT 7600 and 5600 Integrated Systems and the VITROS 3600 Immunodiagnostic System. The VITROS platforms are designed to support community labs running general chemistries, immunoassay tests and drugs of abuse screening. 'We're proud to support healthcare providers who are the backbone of their communities, backed by our award-winning service and top-ranked customer satisfaction,' added Jones. 'This program isn't just about affordability; it's designed to improve accessibility and access of diagnostic solutions for healthcare providers in underserved communities.' QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit and follow QuidelOrtho on LinkedIn, Facebook and X. About QuidelOrtho Corporation QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day. Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed–from home to hospital, lab to clinic. Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions. Investor Contact: Juliet Cunningham Vice President, Investor Relations IR@ Media Contact: D. Nikki Wheeler Senior Director, Corporate Communications Media@

Will Advanced Micro (AMD) Beat Estimates Again in Its Next Earnings Report?
Will Advanced Micro (AMD) Beat Estimates Again in Its Next Earnings Report?

Yahoo

time05-05-2025

  • Business
  • Yahoo

Will Advanced Micro (AMD) Beat Estimates Again in Its Next Earnings Report?

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Advanced Micro Devices (AMD). This company, which is in the Zacks Computer - Integrated Systems industry, shows potential for another earnings beat. This chipmaker has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 1.48%. For the most recent quarter, Advanced Micro was expected to post earnings of $1.07 per share, but it reported $1.09 per share instead, representing a surprise of 1.87%. For the previous quarter, the consensus estimate was $0.91 per share, while it actually produced $0.92 per share, a surprise of 1.10%. Thanks in part to this history, there has been a favorable change in earnings estimates for Advanced Micro lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank. Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Advanced Micro currently has an Earnings ESP of +0.74%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3 (Hold) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on May 6, 2025. With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss. Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate. Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Advanced Micro Devices, Inc. (AMD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store